Sign in

CIK 0001035354

  • Non-accelerated filer
  • Smaller reporting company

Eloxx Pharmaceuticals, Inc.

Sign in to watch
Ticker
ELOX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
841368850
Phone
+1 781-577-5300
Business address
P.O. BOX 274, ARLINGTON, MA, 02476
Former names
Sevion Therapeutics, Inc., SENESCO TECHNOLOGIES INC, NAVA LEISURE USA INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2009-02-27 FORBES CHRISTOPHER Director Purchase +3,000 $0.40 $1K 2,047,021
2009-02-27 FORBES CHRISTOPHER Director Purchase +2,000 $0.39 $780 2,049,021
2009-02-26 FORBES CHRISTOPHER Director Purchase +4,000 $0.40 $2K 2,044,021
2009-02-23 RECTOR DAVID Director Purchase +8,800 $0.45 $4K 36,000
2009-02-20 RECTOR DAVID Director Purchase +6,200 $0.44 $3K 27,200
2009-02-20 RECTOR DAVID Director Grant or award · Common Stock Option +12,766 292,766
2009-02-20 BRACA JOHN N Director Purchase +1,200 $0.40 $480 23,000
2009-02-20 BRACA JOHN N Director Purchase +3,800 $0.42 $2K 23,000
2009-02-20 BRACA JOHN N Director Grant or award · Common Stock Option +12,766 262,766
2009-02-20 FORBES CHRISTOPHER Director Grant or award · Common Stock Option +23,404 337,988
2009-02-20 QUICK THOMAS C Director Grant or award · Common Stock Option +22,340 276,090
2009-02-20 STALDER RUEDI Director Grant or award · Common Stock Option +28,191 726,525
2009-02-20 Van Hulst Jack Director Grant or award · Common Stock +21,277 129,193
2009-02-19 FORBES CHRISTOPHER Director Purchase +882,381 3,044,180

Page 38 of 38 · 754 trades